Pulse Biosciences Income Statement (2020-2025) | PLSE

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.08M0.02M0.01M0.01M-0.11M-0.52M0.57M0.84M0.44M0.30M-0.01M0.09M
Gross Profit -0.15M-0.40M-0.47M-1.04M-1.30M-0.19M
Operating items
Research & Development 9.06M7.46M6.46M5.66M6.77M5.46M4.52M4.09M5.83M6.70M7.47M7.80M6.74M7.23M7.70M10.66M10.31M12.09M11.39M
Selling, General & Administrative 5.32M4.20M4.26M5.30M4.50M3.79M3.09M2.58M3.73M3.53M3.78M4.73M3.87M4.50M5.95M9.60M7.73M8.19M8.78M
Other Operating Expenses 4.15M3.15M4.13M5.29M6.45M5.03M10.42M2.06M0.28M
Operating Expenses 18.52M14.81M14.85M16.25M17.72M14.28M18.02M8.74M9.56M10.23M11.25M12.53M10.62M11.73M13.65M20.26M18.04M20.27M20.45M
Operating Income -14.27M-15.41M-17.27M-14.01M-18.02M-8.74M-9.56M-10.23M-11.25M-12.53M-10.62M-11.73M-13.65M-20.26M-18.04M-20.27M-20.37M
EBIT -14.27M-15.41M-17.27M-14.01M-18.02M-8.74M-9.56M-10.23M-11.25M-12.53M-10.62M-11.73M-13.65M-20.26M-18.04M-20.27M-20.37M
Non-operating items
Interest & Investment Income -0.01M-0.01M0.02M-0.01M-0.45M-0.24M0.32M0.69M0.60M0.48M0.34M0.98M0.87M1.25M1.11M1.00M
Other Non Operating Income -0.00M-0.02M
Non Operating Income -0.01M-0.01M0.02M-0.01M-0.45M-0.24M0.32M0.69M0.60M0.48M0.34M0.97M0.88M1.25M1.11M0.98M
Net income details
EBT -14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.37M
Profit After Tax -18.64M-15.32M-14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.39M
Income from Continuing Operations -14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.37M
Consolidated Net Income -14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.37M
Income towards Parent Company -14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.37M
Net Income towards Common Stockholders -14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.37M
Additional items
EPS (Basic) -0.71-0.58-0.48-0.52-0.58-0.44-0.49-0.22-0.26-0.22-0.19-0.21-0.18-0.20-0.21-0.32-0.25-0.28-0.29
EPS (Weighted Average and Diluted) -0.48-0.58-0.49
Shares Outstanding (Weighted Average) 20.87M20.87M25.21M25.34M26.09M26.46M29.61M29.63M29.80M37.13M37.13M37.23M37.59M37.64M54.90M54.99M55.23M55.23M61.29M67.27M67.27M67.27M67.28M
Shares Outstanding (Diluted Average) 26.48M29.61M31.49M37.16M
EBITDA -18.64M-15.32M-14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.39M
Interest Expenses 0.11M0.52M
Shares Outstanding 25.55M29.72M29.80M37.13M37.23M37.23M37.59M54.77M54.99M55.14M55.23M55.23M61.52M65.93M67.27M67.28M67.74M